| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 315.90B | 252.66B | 250.15B | 247.38B | 246.88B | 266.53B |
| Gross Profit | 98.71B | 73.53B | 78.01B | 78.12B | 78.56B | 81.74B |
| EBITDA | 6.55B | 8.29B | 8.16B | 8.71B | 7.95B | 9.57B |
| Net Income | -2.08B | 265.00M | -2.38B | 1.00B | 928.00M | 1.52B |
Balance Sheet | ||||||
| Total Assets | 130.43B | 129.22B | 130.92B | 132.50B | 132.53B | 133.51B |
| Cash, Cash Equivalents and Short-Term Investments | 10.06B | 11.37B | 11.52B | 16.55B | 15.75B | 17.03B |
| Total Debt | 19.60B | 22.46B | 21.91B | 21.38B | 21.15B | 20.52B |
| Total Liabilities | 56.64B | 54.58B | 56.39B | 53.81B | 54.59B | 55.34B |
| Stockholders Equity | 73.47B | 74.32B | 74.22B | 78.39B | 77.66B | 77.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.84B | -2.28B | 1.95B | -695.00M | 438.00M |
| Operating Cash Flow | 0.00 | 7.62B | 6.60B | 9.69B | 5.93B | 8.59B |
| Investing Cash Flow | 0.00 | -5.75B | -8.74B | -7.94B | -6.68B | -7.02B |
| Financing Cash Flow | 0.00 | -2.02B | -2.88B | -954.00M | -535.00M | -3.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥209.44B | 7.25 | ― | 2.18% | 6.30% | 27.88% | |
73 Outperform | ¥213.16B | 18.46 | 7.56% | 2.70% | 2.28% | 3.61% | |
63 Neutral | ¥229.20B | 17.32 | ― | 3.01% | 18.89% | -34.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥191.78B | -33.75 | ― | 1.77% | 30.67% | ― | |
57 Neutral | ¥194.35B | 8.93 | ― | 1.44% | 1.48% | -33.32% | |
53 Neutral | ¥32.64B | 136.89 | ― | 3.11% | 1.46% | -436.55% |